Close

BIO Testifies At Senate Committee: Private-Sector Drug Coverage Will Help Seniors, Not Price Controls

Jun 13 2000
WASHINGTON, D.C. (June 13, 2000) - Paul Abrams, CEO of NeoRx Corp., testified today on behalf of the Biotechnology Industry Organization (BIO) at a U.S. Senate Health, Education, Labor and Pensions...

Researchers Find No Relationship Between Bt Corn Pollen and Butterfly Larvae Mortality

Jun 5 2000
WASHINGTON (June 5, 2000) - Results of a study publishedtoday indicate that earlier laboratory reports of a relationship between mortality of butterflies and contact with Bt corn are not a reliable...

BIO SUPPORTS NEW GUIDELINES TO ENSURE PATIENT CONFIDENCE IN GENE THERAPY TREATMENT

May 24 2000
(Michael J. Werner, Director of Federal Government Relations/Bioethics Counsel for the Biotechnology Industry Organization (BIO), issued the following statement today regarding the Dept. of Health...

BIO Selects DoubleTwist To Build Web Portal For Life Sciences Researchers, Companies

May 17 2000
WASHINGTON, D.C. and OAKLAND, Calif., May 17, 2000 The Biotechnology Industry Organization (BIO) and DoubleTwist Inc. today announced they signed a letter of intent to collaborate on building a...

BIO CEOs, Lawmakers Talk Policy At Legislative Day

May 15 2000
WASHINGTON, D.C., (May 15, 2000) - BIO anticipatesrecord-breaking attendance at its Legislative Day here Tuesday and Wednesday, May 16 - 17, with about 150 biotech executives expected to...

BIO Says Maine Price Control Law Will Hurt Patients, Stifle Biotech Innovation

May 12 2000
WASHINGTON, D.C. (May 12, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a Maine law that ultimately will result in...

BIO Supportive of FDA Announcement on Biotech Policies

May 3 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding FDA Commissioner Jane Henney’s announcement regarding the agency’s...

XENOTRANSPLANTATION: The Benefits and Risks of Special Organ Transplantation

May 1 2000
A Position Paper fromThe Biotechnology Industry Organization

Executive Summary

1. Human organ transplantation faces a significant challenge because the need for this procedure far exceeds the...

BIO Testifies Proposed Rule On Confidentiality Of Patient Records Could Impede Research

Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Dr. Joanna C. Horobin, testifying on behalf of the Biotechnology Industry Organization (BIO), said today the Clinton administration’s proposed rule for...

Gorton Bill Will Result In Price Controls, Hurting Seniors, Not Helping Them

Apr 26 2000
WASHINGTON, D.C. (April 26, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to U.S. Sen. Slade Gorton’s (R-Wash.)...